Inhibitors | Comment | Organism | Structure |
---|---|---|---|
heparin | non-competitive inhibitor using fragment(1-24) of human basic fibroblast growth factor as xylose acceptor | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0208 | - |
fragment(1-24) of human basic fibroblast growth factor | native XT-I | Homo sapiens | |
0.0223 | - |
fragment(1-24) of human basic fibroblast growth factor | recombinant XT-I | Homo sapiens | |
0.0572 | - |
human basic fibroblast growth factor | native XT-I | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
extracellular | - |
Homo sapiens | - |
- |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
blood serum | patients with osteoarthritis | Homo sapiens | - |
culture supernatant | of JAR choriocarcinoma cells secrete six times more XT-I than the osteogenic sarcoma cell line SAOS-2 and 40times more XT-I than the fibroblast cell line hTERT-BJ1 | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
UDP + fragment(1-24) of human basic fibroblast growth factor | - |
Homo sapiens | UDP + ? | - |
? | |
UDP + human basic fibroblast growth factor | transfer of xylose to the serine residue of the G-S-G-motif in the amino terminal end of human basic fibroblast growth factor | Homo sapiens | UDP + ? | - |
? | |
UDP-D-xylose + bikunin | - |
Homo sapiens | UDP + D-xylosyl-bikunin | - |
? |
Synonyms | Comment | Organism |
---|---|---|
XT-I | - |
Homo sapiens |